Firstly, the number of bladder cancer cells passed through the transwell membrane was observed to be reduced by siRNA‐mediated knockdown of IGF2BP3 in T24, suggesting that silencing IGF2BP3 could inhibit cell migration in bladder cancer (Figure S1A). Here, IGF2BP3 is linked to urinary bladder carcinoma.